We are live on ! Find out more
BMY icon

Bristol-Myers Squibb
BMY

1,179 hedge funds and large institutions have $49.8B invested in Bristol-Myers Squibb in 2013 Q2 according to their latest regulatory filings, with 1,179 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.53% more ownership

Funds ownership: 0% → 68.53% (+69%)

1% more call options, than puts

Call options by funds: $519M | Put options by funds: $516M

Holders
1,179
Holders Change
+1,179
Holders Change %
–
% of All Funds
38.47%
Holding in Top 10
49
Holding in Top 10 Change
+49
Holding in Top 10 Change %
% of All Funds
1.6%
New
1,179
Increased
–
Reduced
–
Closed
–
Calls
$519M
Puts
$516M
Net Calls
+$2.99M
Net Calls Change
+$2.99M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCC
901
Foster Dykema Cabot & Co
Massachusetts
$502K +$488K +11,240 New
ST
902
Stifel Trust
Missouri
$501K +$486K +11,200 New
BCM
903
Bluefin Capital Management
New York
$500K +$452K +10,421 New
PRHC
904
P.R. Herzig & Co
New York
$499K +$484K +11,158 New
MAM
905
Mastrapasqua Asset Management
Tennessee
$497K +$483K +11,130 New
EWA
906
Exencial Wealth Advisors
Oklahoma
$495K +$496K +11,422 New
FANJ
907
Financial Architects (New Jersey)
New Jersey
$494K +$480K +11,048 New
AIC
908
Atlantic Investment Company
Georgia
$488K +$474K +10,920 New
HMS
909
Hanseatic Management Services
New Mexico
$487K +$473K +10,887 New
HI
910
Hudock Inc
Pennsylvania
$486K +$472K +10,874 New
BSWMG
911
Barrington Strategic Wealth Management Group
Illinois
$484K +$470K +10,830 New
LPC
912
Loeb Partners Corp
New York
$483K +$469K +10,810 New
LC
913
Lourd Capital
California
$483K +$469K +10,811 New
MA
914
MCF Advisors
Kentucky
$482K +$403K +9,276 New
LCP
915
Legacy Capital Partners
Wisconsin
$482K +$468K +10,775 New
DMC
916
Drexel Morgan & Co
Pennsylvania
$478K +$464K +10,692 New
NSAM
917
North Star Asset Management
Wisconsin
$477K +$463K +10,675 New
BRA
918
Bender Robert & Associates
California
$476K +$463K +10,655 New
CFA
919
Carroll Financial Associates
North Carolina
$475K +$462K +10,651 New
MA
920
Montag & Associates
Georgia
$469K +$456K +10,500 New
HW
921
Hancock Whitney
Mississippi
$467K +$454K +10,450 New
FAT
922
First American Trust
California
$464K +$451K +10,378 New
HCM
923
Hutchinson Capital Management
California
$462K +$448K +10,327 New
AI
924
Atria Investments
North Carolina
$461K +$448K +10,320 New
FNBOMD
925
First National Bank of Mount Dora
Florida
$459K +$446K +10,263 New
35 36
37
38 39

BMY Hedge Fund Activity: Q2 2013 in Review

1,179 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2013, worth a combined $49.8B.

Buyers outnumbered sellers: 1,179 funds opened new BMY positions and 0 closed out — a net gain of 1,179 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,179 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $49.8B of Bristol-Myers Squibb stock for Q2 2013.
  • 1,179 funds opened new Bristol-Myers Squibb positions in Q2 2013 and 0 closed out, a net change of +1,179 holders.

Based on aggregated 13F filings for Q2 2013.